KARA BABAIAN to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications KARA BABAIAN has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.152
-
Urinary bother, Urinalysis, and Two-Year Efficacy Follow-Up Results of Phase I Trial of Intravesical Bacillus Calmette-Gu?rin Combined with Intravenous Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder Cancer after Previous Bacillus Calmette-Gu?rin Treatment. Clin Genitourin Cancer. 2024 06; 22(3):102059.
Score: 0.152